Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    Aurobindo Pharma Shares Tumble 2% Despite Q1 Profit Jump, Double Digit Revenue Guidance For FY27

    1 day ago

    The scrip has risen 35.19% year-to-date and 49.16% in the last 12 months. Out of 28 analysts tracking the company on Bloomberg, 19 recommend buying its shares, five have a 'hold' call, and four suggest selling it.
    Click here to Read More
    Previous Article
    Defence Stock Rallies: HAL Share Price Jumps 6% In Trade. Here's Why
    Next Article
    Trent Shares Down 2% Ahead Of Q1 Results — What To Expect?

    Related Business Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment